Copenhagen, Denmark · AcceleratorAccelerace is Denmark's longest-running accelerator and pre-seed investor, founded in 2008 to help early-stage teams validate products, refine go-to-market strategy, and access investors. The program runs multiple tracks across general tech, life science, and sustainability, and pairs founders with a large mentor network. Accelerace also invests small tickets in selected teams and helps them prepare for follow-on funding. It has supported 800+ Nordic startups and remains a core launchpad in the Danish ecosystem.
AcceleratorPre-Seed to SeedGeneral TechLife ScienceSustainability
Copenhagen, Denmark · IncubatorBioInnovation Institute is a life science incubator backed by the Novo Nordisk Foundation that helps researchers and founders turn biotech and health innovations into venture ready companies. Based in Copenhagen, BII provides lab space, grant funding, expert business support, and access to investors for projects in therapeutics, diagnostics, and industrial biotech. It runs programs for both idea stage research and early startups, de risking science heavy ventures before they seek larger capital. BII is a central node in the Danish life science startup pipeline.
IncubatorBiotechHealthtechLife Science
Lyngby, Denmark · Event OrganisatorOrganizes courses focused on leading the bio-revolution across life science, offering executive education and leadership development for professionals in biotechnology and related fields.
Event OrganisatorBiotechnologyLife ScienceEducationLeadershipEvents
Lyngby, Denmark · EventCourse designed to equip leaders with insights and strategies for navigating and driving innovation in the life science bio-revolution. Focuses on emerging trends and leadership challenges in the sector.
EventBiotechnologyLife ScienceEducationEvents
Hellerup, Denmark · Venture CapitalNovo Holdings is the investment arm of the Novo Nordisk Foundation and the largest life science investor in Denmark. It backs biotech, medtech, and health innovation across seed, venture, and growth stages while also managing the foundation's long term ownership in Novo Nordisk and Novozymes. The firm provides patient capital, deep scientific expertise, and global networks for founders building therapies, diagnostics, and industrial biotech solutions. Novo Holdings is a cornerstone of the Danish life science ecosystem.
Venture CapitalSeed to GrowthBiotechLife ScienceHealthcare